Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A quality improvement project to address the challenges surrounding zoledronic acid use in children

Journal of Bone and Mineral Metabolism(2021)10.1007/s00774-021-01214-5Source: DataRank Database

A quality improvement project to address the challenges surrounding zoledronic acid use in children is a research paper published in Journal of Bone and Mineral Metabolism (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: bronzeTopics (50)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

María Cristina Gil-Díaz ORCID,Silvia Louis,Noya Rackovsky,Roman Rahmani ORCID,Sierra D. Stauber

Live enrichment

PubMed:33825940 PMC:PMC8025437 OpenAlex:https://openalex.org/W3140042212

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK114477

NIDDK NIH HHS

Grant: K23 DK114477

National Institutes of Health

Grant: 5K23DK114477-03

Investigation of Hypercalciuria as a Cause of Impaired Bone Mineral Accrual in Type 1 Diabetes

FWCI

0.00

Citation Percentile

0.0%

bronzeLicense: Springer Nature TDM

journalhttps://link.springer.com/content/pdf/10.1007/s00774-021-01214-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00774-021-01214-5.pdf

publisherhttps://link.springer.com/article/10.1007/s00774-021-01214-5/fulltext.html

journalhttps://doi.org/10.1007/s00774-021-01214-5

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8025437

Fields of Study

Bone health and treatmentsBone health and osteoporosis researchParathyroid Disorders and Treatments0301 basic medicine03 medical and health sciences0302 clinical medicineAdministration, IntravenousBone Density Conservation AgentsChildDiphosphonatesFemaleHumansInfusions, IntravenousMaleQuality ImprovementTreatment OutcomeZoledronic Acid

MeSH Terms

Zoledronic AcidChildDiphosphonatesFemaleHumansInfusions, IntravenousMaleTreatment OutcomeBone Density Conservation AgentsQuality ImprovementAdministration, Intravenous

Keywords

MedicineZoledronic acidGuidelineQuality managementAdverse effectPsychological interventionInternal medicineNursingOsteoporosisQuality improvementQuality assessmentBisphosphonatesMaleBone Density Conservation AgentsDiphosphonatesTreatment OutcomeHumansOriginal ArticleAdministration, IntravenousFemaleChildInfusions, Intravenous

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

A quality improvement project to address the challenges surrounding zoledronic acid use in children

FAIR Checklist

Authors (6)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)